PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
25.52%
Positive revenue growth while AVGO is negative. John Neff might see a notable competitive edge here.
13.52%
Gross profit growth above 1.5x AVGO's 2.66%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-33.30%
Negative EBIT growth while AVGO is at 7.51%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-33.30%
Negative operating income growth while AVGO is at 7.51%. Joel Greenblatt would press for urgent turnaround measures.
-32.17%
Negative net income growth while AVGO stands at 8.35%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-32.43%
Negative EPS growth while AVGO is at 9.37%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-32.43%
Negative diluted EPS growth while AVGO is at 10.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.33%
Share count expansion well above AVGO's 0.49%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.64%
Diluted share count expanding well above AVGO's 0.23%. Michael Burry would fear significant dilution to existing owners' stakes.
0.69%
Dividend growth above 1.5x AVGO's 0.09%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
72.39%
OCF growth above 1.5x AVGO's 14.65%. David Dodd would confirm a clear edge in underlying cash generation.
79.05%
FCF growth above 1.5x AVGO's 14.80%. David Dodd would verify if the firm’s strategic investments yield superior returns.
343.12%
10Y revenue/share CAGR at 50-75% of AVGO's 605.29%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
194.48%
5Y revenue/share CAGR above 1.5x AVGO's 78.46%. David Dodd would look for consistent product or market expansions fueling outperformance.
68.02%
3Y revenue/share CAGR above 1.5x AVGO's 35.36%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
4142.41%
10Y OCF/share CAGR above 1.5x AVGO's 749.63%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
744.30%
5Y OCF/share CAGR above 1.5x AVGO's 448.57%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
115.41%
3Y OCF/share CAGR above 1.5x AVGO's 58.43%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
510.29%
Similar net income/share CAGR to AVGO's 560.82%. Walter Schloss would see parallel tailwinds or expansions for both firms.
2001.04%
5Y net income/share CAGR above 1.5x AVGO's 220.35%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
3.40%
Positive short-term CAGR while AVGO is negative. John Neff would see a clear advantage in near-term profit trajectory.
368.66%
10Y equity/share CAGR at 50-75% of AVGO's 699.57%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
191.99%
5Y equity/share CAGR above 1.5x AVGO's 16.29%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
125.76%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
64.05%
Below 50% of AVGO's 627.34%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
14.22%
Below 50% of AVGO's 108.03%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
9.28%
Our AR growth while AVGO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
24.20%
Inventory growth well above AVGO's 5.46%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.28%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.88%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
1.54%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
35.65%
R&D growth drastically higher vs. AVGO's 2.23%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
113.99%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.